Shibata Kiyosumi | Department Of Obstetrics & Gynecology Nagoya University School Of Medicine
スポンサーリンク
概要
関連著者
-
Shibata Kiyosumi
Department Of Obstetrics And Gynecology Nagoya University Graduate School Of Medicine
-
Kikkawa Fumitaka
Department Of Obstetrics And Gynecology Nagoya University Graduate School Of Medicine
-
Kikkawa Fumitaka
名古屋大学 医学系研究科産婦人科学
-
Kikkawa Fumitaka
Department Of Gynecology And Obstetrics Nagoya University Graduate School Of Medicine
-
Shibata Kiyosumi
Department Of Obstetrics & Gynecology Nagoya University School Of Medicine
-
Kikkawa Fumitaka
Department Of Obstetrics & Gynecology Nagoya University School Of Medicine
-
Sakakibara Katsumi
Department Of Obstetrics And Gynecology Nagoya University Graduate School Of Medicine
-
Kawai Hiroki
Department Of Gastroenterology Aichi Cancer Center Hospital
-
Kajiyama Hiroaki
Department Of Obstetrics And Gynecology Nagoya University Graduate School Of Medicine
-
Kajiyama Hiroaki
Department Of Gastroenterology Aichi Cancer Center Hospital
著作論文
- Gene silencing of glypican-3 in clear cell carcinoma of the ovary renders it more sensitive to the apoptotic agent paclitaxel in vitro and in vivo
- IS-39 Expression of CD117, CD133, SALL4, OCT4, TCL1, and Glypican-3 (stem cell markers) in malignant germ cell tumors of the ovary(Group5 Oncology5,International Session)
- Advances in treatment of epithelial ovarian cancer
- The expression of dipeptidyl peptidase IV (DPPIV/CD26) is associated with enhanced chemosensitivity to paclitaxel in epithelial ovarian carcinoma cells
- Feasibility and effectiveness of postoperative adjuvant concurrent chemoradiation therapy in Japanese patients with high-risk early-stage cancer of the uterine cervix
- LONG-TERM OUTCOME AND PROGNOSTIC FACTORS FOR YOLK SAC TUMOR OF THE OVARY
- IS-20 Dipeptidyl peptidase IV/CD26 Expression in Endometrial Endometrioid Adenocarcinoma and Its Inverse Correlation with Tumor Grade
- Identification and characterization of cancer stem cells in ovarian yolk sac tumors
- Mismatched human leukocyte antigen class II-restricted CD8^+ cytotoxic T cells may mediate selective graft-versus-leukemia effects following allogeneic hematopoietic cell transplantation
- Glypican-3 could be an effective target for immunotherapy combined with chemotherapy against ovarian clear cell carcinoma